By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Diffusion Pharmaceuticals 

2020 Avon Court, Suite 4

Charlottesville  Virginia  22902  U.S.A.
Phone: 434-220-0718 Fax: 434-220-0722



Drug Discovery

Company News
Diffusion Pharma Provides Corporate Highlights And Reports Financial First Quarter 2017 Results 5/16/2017 10:56:29 AM
Diffusion Pharma Awarded U.S. Patent For TSC As Therapeutic In Five Hypoxia-Related Indications 4/4/2017 11:46:00 AM
Diffusion Pharma Announces Closing Of Oversubscribed Private Placement 4/3/2017 1:32:32 PM
Diffusion Pharma Provides Corporate Highlights And Reports 2016 Financial Results 3/31/2017 9:44:26 AM
Diffusion Pharma’ TSC Phase I/II Glioblastoma Multiforme Clinical Trial Results Published In February 2017 Edition Of Journal Of Neurosurgery 2/8/2017 8:40:06 AM
Diffusion Pharma Files Definitive Proxy Statement For Upcoming Special Meeting Of Stockholders 12/12/2016 7:29:50 AM
Diffusion Pharma Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results 11/14/2016 8:05:08 AM
Diffusion Pharma Announces Uplisting To NASDAQ Capital Market 11/8/2016 7:49:14 AM
Diffusion Pharma Establishes Scientific Advisory Board 9/29/2016 11:05:29 AM
Diffusion Pharma Successfully Completes Animal Toxicity Studies In Preparation For Phase III Pivotal Trial Of TSC In New Diagnosed Glioblastoma Patients 9/19/2016 8:36:35 AM